Author
Listed:
- Helen Luck
(University Health Network
University of Toronto
10-352 Toronto Medical Discovery Tower)
- Saad Khan
(University Health Network
University of Toronto
10-352 Toronto Medical Discovery Tower)
- Justin H. Kim
(University Health Network)
- Julia K. Copeland
(University of Toronto)
- Xavier S. Revelo
(University of Minnesota
University of Minnesota)
- Sue Tsai
(University Health Network
University of Alberta)
- Mainak Chakraborty
(University Health Network)
- Kathleen Cheng
(University Health Network
University of Toronto)
- Yi Tao Chan
(University Health Network
University of Toronto)
- Mark K. Nøhr
(University Health Network)
- Xavier Clemente-Casares
(University Health Network
University of Alberta)
- Marie-Christine Perry
(University of Toronto)
- Magar Ghazarian
(University Health Network)
- Helena Lei
(University Health Network)
- Yi-Hsuan Lin
(University Health Network
Chang Gung University)
- Bryan Coburn
(University of Toronto
University Health Network
University of Toronto)
- Allan Okrainec
(University Health Network
University of Toronto)
- Timothy Jackson
(University Health Network
University of Toronto)
- Susan Poutanen
(University of Toronto
University of Toronto
University Health Network/Sinai Health System)
- Herbert Gaisano
(University of Toronto)
- Johane P. Allard
(University of Toronto
University Health Network)
- David S. Guttman
(University of Toronto)
- Margaret E. Conner
(Baylor College of Medicine)
- Shawn Winer
(University of Toronto
St. Michael’s Hospital)
- Daniel A. Winer
(University Health Network
University of Toronto
University of Toronto
University Health Network)
Abstract
The intestinal immune system is emerging as an important contributor to obesity-related insulin resistance, but the role of intestinal B cells in this context is unclear. Here, we show that high fat diet (HFD) feeding alters intestinal IgA+ immune cells and that IgA is a critical immune regulator of glucose homeostasis. Obese mice have fewer IgA+ immune cells and less secretory IgA and IgA-promoting immune mediators. HFD-fed IgA-deficient mice have dysfunctional glucose metabolism, a phenotype that can be recapitulated by adoptive transfer of intestinal-associated pan-B cells. Mechanistically, IgA is a crucial link that controls intestinal and adipose tissue inflammation, intestinal permeability, microbial encroachment and the composition of the intestinal microbiome during HFD. Current glucose-lowering therapies, including metformin, affect intestinal-related IgA+ B cell populations in mice, while bariatric surgery regimen alters the level of fecal secretory IgA in humans. These findings identify intestinal IgA+ immune cells as mucosal mediators of whole-body glucose regulation in diet-induced metabolic disease.
Suggested Citation
Helen Luck & Saad Khan & Justin H. Kim & Julia K. Copeland & Xavier S. Revelo & Sue Tsai & Mainak Chakraborty & Kathleen Cheng & Yi Tao Chan & Mark K. Nøhr & Xavier Clemente-Casares & Marie-Christine , 2019.
"Gut-associated IgA+ immune cells regulate obesity-related insulin resistance,"
Nature Communications, Nature, vol. 10(1), pages 1-17, December.
Handle:
RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-11370-y
DOI: 10.1038/s41467-019-11370-y
Download full text from publisher
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Pai Wang & Xin Yang & Luyao Zhang & Sha Sha & Juan Huang & Jian Peng & Jianlei Gu & James Alexander Pearson & Youjia Hu & Hongyu Zhao & F. Susan Wong & Quan Wang & Li Wen, 2024.
"Tlr9 deficiency in B cells leads to obesity by promoting inflammation and gut dysbiosis,"
Nature Communications, Nature, vol. 15(1), pages 1-16, December.
- Isaac G. Crusoe & Ian C. Chiwaya & Tasnim I. Habib, 2024.
"Immune Control of Gut Microbiota Prevents Obesity and the Effect of Antibiotic on Microbial Population,"
International Journal of Research and Scientific Innovation, International Journal of Research and Scientific Innovation (IJRSI), vol. 11(5), pages 1-9, May.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-11370-y. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.